- Cholesterol is essential — for cell membranes, hormones, vitamin D and digestion; most is made by the liver, not from food.
- HDL ("good") removes excess; LDL ("bad") can oxidise and form arterial plaques (atherosclerosis) amid chronic inflammation.
- The medix position: inflammation (driven heavily by sugar), not dietary cholesterol, is the real root cause.
- Beyond statins: a ketogenic approach and a multi-pathway mushroom-based formula are presented as alternatives — discuss any change with your doctor.
What is cholesterol, and why do we have it?
The body cannot function without cholesterol. It helps the body break down fats (lipids) in the small intestine so they can be absorbed into the bloodstream. In the liver, cholesterol combines with lipids and proteins to form complex compounds called lipoproteins. Cholesterol is essential for forming cell membranes, producing hormones, digesting food, and contributing to vitamin D production when the skin is exposed to sunlight. It allows human cells to move and change shape (which plants cannot do, because they have no cholesterol). Fundamentally, it is needed for the production and growth of new cells — which is why there is so much cholesterol in eggs.

High cholesterol
So where does the problem of high cholesterol lie? Evidently, in too much production in the liver. A cholesterol level that is too high is associated with cardiovascular disease: atherosclerosis, stroke, heart attack, heart failure, pericarditis, coronary heart disease. Heart disease is the world's number-one killer (the second is cancer).26 The body has a mechanism to regulate the cholesterol balance: it produces so-called "good" cholesterol (HDL — high-density lipoprotein) which removes the "bad."
Are there two cholesterols? Good (HDL) and bad (LDL)?

LDL cholesterol is the one called "bad." Why is it called bad, when it is one of the most important substances in the body — without it we would die? An excessive amount of this cholesterol is associated with coronary heart disease, heart attack, stroke and other circulatory and heart-related conditions. When the artery walls are damaged (we discuss why below), LDL cholesterol is sent to the site of damage as a "repair material." The problem arises when, because of unceasing inflammation, LDL becomes trapped inside the artery wall, oxidises, and together with immune cells forms plaques. This process, which narrows the arteries, is called atherosclerosis.
Cholesterol levels (norms)
At first glance, blood cholesterol figures can seem a little complicated. Cholesterol is measured in millimoles per litre of blood (sometimes mg/dl).
| Measure | Range | Meaning |
|---|---|---|
| Total cholesterol | < 5 mmol/l | Normal |
| Total cholesterol | 5–6 mmol/l | Borderline |
| Total cholesterol | > 6 mmol/l | Too high |
| LDL (lower is better) | < 1.4 mmol/l | Target for people with heart disease or high risk |
| LDL | < 1.8 mmol/l | Target for people with heart disease or attack risk |
| LDL | < 3.0 mmol/l | Normal |
| LDL | > 5.0 mmol/l | Very high |
| HDL (higher is better) | < 1 mmol/l (men), < 1.2 mmol/l (women) | Very poor |
So where does TOO MUCH cholesterol come from?
The key question remains: why does your body produce too much cholesterol (we have already established that elevated cholesterol does not "come from" food, as you are usually led to believe)? "It's the genes!" your doctor may say; "Yes, it's DNA!" echo the big drug manufacturers. But do you really believe it is your grandmother's fault? Then where were the cholesterol problems, say, 300 years ago? Back then people consumed two or three times more calories per day, most of it from animal-source food. Genes do not change that fast, so a cholesterol "epidemic" (like the one now) would already have existed centuries ago. The cause lies elsewhere.
Cholesterol drugs (statins)
As mentioned, cholesterol is produced in the body. This synthesis is a complex process involving about 30 chemical reactions. The critical moment is when the enzyme HMG-CoA reductase produces mevalonate. This enzyme is especially significant because it controls whether cholesterol is produced or not. Because HMG-CoA reductase is the critical controller of cholesterol synthesis, statins intervene in this reaction and block it — and presto, cholesterol production is halted. But this does not address why the enzyme keeps receiving the signal to produce cholesterol in the first place.
Side effects of cholesterol drugs

The active ingredient in most cholesterol-lowering drugs prescribed to you is "statins." It is worth looking into their side effects — and the likelihood of them is considerable. And you would have to take them for life. Dr. Malcolm Kendrick argues that the drawbacks of statins outweigh the potential benefit for many people. Statin prescriptions rise by nearly 30% every year. Patients should ask their doctors: "How much longer will I live if I take statins — and what will the quality of that time be?"
What really drives high cholesterol
This may be entirely unexpected, but there is a great deal of research, and those who look can readily find the answers. So what drives excessive cholesterol production in your body? In short — sugar (glucose). How does this happen? It is known that cholesterol forms atherosclerotic plaques in the arteries and clogs blood vessels. But once you understand that cholesterol is a tool for controlling inflammation and managing the damage inflammation causes, the picture of the "system" becomes clear. The cause of chronic disease is inflammation, not cholesterol.20 The real culprit is inflammation — and what most inflames your blood vessels? Sugar causes enormous inflammation.
Lowering cholesterol
As mentioned, for many people taking cholesterol-lowering drugs (statins) can be dangerous. The best diet in that case is ketogenic. This diet is fairly hard to follow, because the proportions of all foods are the reverse of what we are used to. About 80% of all calories should come from fats (good fats, not heated oils or trans fats), about 15% from protein, and about 5% from carbohydrates — only from non-starchy vegetables (no starch). That means cauliflower, broccoli, courgette, cucumber and all leafy greens. So no porridge, no buns, no potatoes, bread, alcohol, fruit, flour or sugar.
How to maximally lower your cholesterol and improve your circulatory system without statins?
The answer is medicinal mushrooms. The first-generation statins were extracted from mushrooms and had no side effects. Do you know the biggest problem with medicinal mushrooms? They cannot be patented (the "patent" belongs to nature), so the big drug companies cannot monopolise markets and generate enormous cash flows. In Asia, medicinal mushrooms have been used for centuries, while in the Western hemisphere mushroom research has only been "catching up" in recent decades. Research scientifically supports the traditional use of medicinal mushrooms — and a precision formula combining several complementary cholesterol pathways is more effective than any single ingredient.
First-generation statins came from mushrooms. A precision formula combining several complementary cholesterol pathways is studied as more effective than any single ingredient.
AURI 25 by Zenius Labs™ →Total cholesterol below 5 mmol/l is normal, 5–6 mmol/l is borderline, and above 6 mmol/l is too high. For LDL, below 3.0 mmol/l is normal, while people with heart disease or high risk aim for below 1.4–1.8 mmol/l. HDL should be above 1 mmol/l (men) or 1.2 mmol/l (women).
Most cholesterol is produced in the liver, not obtained from food. The medix position is that excess production is driven largely by chronic inflammation — with sugar (glucose) a major inflammatory trigger — rather than by dietary cholesterol or genetics alone.
HDL (high-density lipoprotein) is the "good" cholesterol that removes excess from the body. LDL (low-density lipoprotein) is called "bad" because, amid chronic inflammation, it can become trapped in artery walls, oxidise, and form plaques (atherosclerosis). Both are essential to life.
A ketogenic diet and medicinal mushrooms are presented as approaches. The first-generation statins were themselves extracted from mushrooms. A precision formula combining several complementary cholesterol pathways, such as AURI 25 by Zenius Labs™, is studied as more effective than single ingredients. Always discuss any change with your doctor.
- Auricularia auricula — hypolipidemic properties. PubMed
- Polysaccharide-based cholesterol reduction mechanisms. PubMed
- Edible mushrooms — cardiovascular disease prevention. PubMed
- Beta-glucan dietary fiber and cholesterol. PubMed
- Medicinal mushrooms — cardiovascular review. PMC
- Auricularia polysaccharide — antithrombotic effects. PubMed
- Fungal polysaccharides — immunomodulatory activity. PubMed
- Auricularia auricula — hepatoprotective properties. PubMed
- Fungal polysaccharides — oxidative stress reduction. PubMed
- Dietary fiber and serum cholesterol reduction. PubMed
- Statin alternatives — natural compounds review. PubMed
- Plant sterols and cholesterol absorption. PubMed
- Mushroom extracts — lipid-lowering clinical evidence. PubMed
- Functional food compounds and dyslipidemia. PubMed
- Polysaccharide supplementation — metabolic outcomes. PubMed
- Dietary fiber — cardiovascular risk factors. PubMed
- Statin side effects — systematic review. PMC
- Auricularia polysaccharide structure and bioactivity. ScienceDirect
- Yuan Z et al. (1998) Hypoglycemic effect of A. auricula-judae. Biosci Biotechnol Biochem
- Yoona S-J et al. (2003) Anticoagulant polysaccharide from A. auricula. Thrombosis Research
- Francia C et al. (1999) Mushrooms and cardiovascular diseases. Int J Medicinal Mushrooms
- Auricularia auricula — antioxidant capacity. PubMed
- Medicinal mushrooms — therapeutic potential review. PubMed
- World Health Organization — cardiovascular disease statistics
- Natural lipid-lowering agents — clinical review. PMC
- Statin drug side effects — patient information. WebMD
- Netherlands RADAR survey — statin side effects. SpaceDoc
- American Diabetes Association
- Zhang Z et al. (2011) Auricularia polysaccharide prevents oxidative stress. Carbohydrate Polymers, 84(1), 638-648
- Chen Y et al. (2008) A. auricula polysaccharide — blood lipid metabolism. J Food Science, 73(6)
- Ikekawa T et al. (1968) Antitumor activity of edible mushroom extracts. Cancer Research, 29(3), 734-5
- Kho S et al. (2009) Antioxidant capacity of A. auricula-judae. J Medicinal Food, 12(1), 167-174
- Wu Z et al. (2010) A. auricula polysaccharides and heart enzymes. Int J Biol Macromolecules, 46(3), 284-288
- Luo G et al. (2009) Antioxidative properties of A. auricula and hawthorn. Innovative Food Science, 10(2), 215-221
- Glass CK, Witztum JL (2001) Atherosclerosis: The Road Ahead. Cell, 104(4), 503-516
- Giugliano D (2000) Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc Dis, 10(1), 38-44
- Shahidi F (2004) Functional foods: health promotion and disease prevention. J Food Science, 69(5), 146-149
- Misaki A et al. (1981) Antitumor polysaccharides from A. auricula-judae. Carbohydrate Research, 92(1), 115-29
- Barclay AW et al. (2008) Glycemic index and chronic disease risk. Am J Clin Nutr, 87, 627-37
- Boden G et al. (2005) Low-carbohydrate diet on appetite and blood glucose. Annals Internal Medicine, 142
- Brownlee M (2005) Pathology of diabetic complications. Diabetes, 1615-1625
- Djoussé L, Gaziano JM (2009) Dietary cholesterol and coronary artery disease. Atheroscler Rep, 11(6), 418-22
- Eaton SB et al. (1988) Stone agers in the fast lane. Am J Med, 84, 739-749
- Esposito K et al. (2002) Inflammatory cytokines and hyperglycemia. Circulation, 106, 2067-2072
- Greco TP et al. Oxidized-LDL complexes in acute coronary syndromes. Am J Clin Path, 133, 737-743
- Halton TL et al. (2006) Low carbohydrate diet and CVD in women. NEJM, 355, 1991-2002
- Jakobsen MU et al. (2010) Carbohydrates vs saturated fatty acids. Am J Clin Nutr, 91, 1764-8
- Mente A et al. (2009) Dietary factors and coronary heart disease. Arch Internal Medicine, 169(7), 659-69
- Siri-Tarino PW et al. (2010) Saturated fat, carbohydrate, and CVD. Am J Clin Nutr
- Welsh JA et al. (2010) Caloric sweetener and dyslipidemia. JAMA, 303(15), 1490-1497
- Westman EC et al. (2007) Low-carbohydrate nutrition and metabolism. Am J Clin Nutr, 86, 276-84
- Willett W (2011) The Great Fat Debate. J Am Diet Assoc, 111(5), 660-662
- Fan L et al. (2006) Auricularia Auricula Polysaccharide Flour. Food Chemistry, 101(3), 1158-1163
- Kaliora AC et al. (2006) Dietary Antioxidant in Preventing Atherogenesis. Atherosclerosis, 187(1), 1-17
- Chen Y et al. (2010) Hypocholesterolemic Effects of Auricularia Auricula Ethanol Extract
- Yoon SJ et al. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thrombosis research. 2003. PubMed
- Bian C et al. A Novel Polysaccharide from AuriculariaAuricula Alleviates Thrombosis Induced by Carrageenan in Mice. Molecules (Basel, Switzerland). 2022. PubMed
- Shi Q et al. Isolation, Characterization, and Antioxidant Activity of Melanin from Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2023. PubMed
- Yin CM et al. Physicochemical Properties and Antioxidant Activity of Natural Melanin Extracted from the Wild Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2022. PubMed
- Liu X et al. Comprehensive utilization of edible mushroom Auricularia auricula waste residue-Extraction, physicochemical properties of melanin and its antioxidant activity. Food science & nutrition. 2019. PubMed
- González-Bonilla A et al. Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico. International journal of medicinal mushrooms. 2022. PubMed
- Abrams DI et al. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC complementary and alternative medicine. 2011. PubMed
- Belobrajdic DP et al. β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp. Food & function. 2024. PubMed
- Maheshwari G et al. Characterization of the Nutritional Composition of a Biotechnologically Produced Oyster Mushroom and its Physiological Effects in Obese Zucker Rats. Molecular nutrition & food research. 2020. PubMed
- Sato M et al. Long-term intake of Tamogi-take mushroom (Pleurotus cornucopiae) mitigates age-related cardiovascular dysfunction and extends healthy life expectancy. npj aging. 2025. PubMed
- Gong J et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Molecular nutrition & food research. 2018. PubMed
- Chen JT et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005. PubMed
- Millán J et al. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 2016. PubMed
- Singh DK et al. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. The Journal of pharmacology and experimental therapeutics. 2006. PubMed
- Castaño G et al. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clinical drug investigation. 2003. PubMed
- Xiong Z et al. An overview of the bioactivity of monacolin K / lovastatin. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019. PubMed
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. Scientific Opinion on additional scientific data related to the safety of monacolins from red yeast rice submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006. EFSA journal. European Food Safety Authority. 2025. PubMed
- Peng D et al. Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults. The American journal of nursing. 2017. PubMed
- Gerards MC et al. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis. Atherosclerosis. 2015. PubMed
- Cicero AFG et al. Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients. 2023. PubMed
- Buzzelli L et al. Alternative lipid lowering strategies: State-of-the-art review of red yeast rice. Fitoterapia. 2024. PubMed
- Hermans MP et al. The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. Frontiers in pharmacology. 2023. PubMed
- Sun HJ et al. Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice. Cardiovascular diabetology. 2024. PubMed
- Park C et al. Disturbed flow induces reprogramming of endothelial cells to immune-like and foam cells under hypercholesterolaemia during atherogenesis. Cardiovascular research. 2025. PubMed
- Zhang S et al. Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytotherapy research : PTR. 2021. PubMed
- Wang J et al. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice. Journal of the American Heart Association. 2017. PubMed